Aiomic Secures 10 Million DKK in Funding to Reduce Postoperative Complications with AI-Powered Platform

We are excited to announce that we have secured 10 million Danish Kroner (DKK) in funding through convertible loans to further develop and commercialize our platform, Aiomic360. Our platform aims to reduce the number of postoperative complications, which currently presents a significant burden for patients, healthcare systems, and payers.

​Utilizing the power of artificial intelligence (AI), Aiomic360 assists healthcare managers and surgeons in making informed decisions regarding patient care. By analyzing patient data and identifying risk factors, the platform can help reduce the likelihood of postoperative complications, such as infections and readmissions.

Postoperative complications account for a substantial portion of healthcare costs and can have long-lasting impacts on patients' quality of life. Addressing this issue, our platform has the potential to improve patient outcomes while reducing healthcare costs.
​
The funding will be used to further develop the platform and bring it to market. The funding was provided by BioInnovation Institute who believe in our vision for using AI to improve patient outcomes and reduce healthcare costs. With this funding, we are well-positioned to continue our mission of bringing cutting-edge technology to healthcare.